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within the proximal rhodopsin promoter region to enhance tran-critical for photoreceptor development), and demonstrates synergy
in enhancing the activity of the rhodopsin promoter. NRL also binds1. Structure
The protein NRL (neural retina leucine zipper) (Uniprot Acces-
sion #P54845) is a basic motif-leucine zipper (bZIP) transcription
factor of theMaf sub-family, involved in cellular differentiation and
gene regulation, that has an essential intrinsic role in the devel-
opment of rod photoreceptors (Mears et al., 2001 (cited within
Nichols et al., 2010)). The gene is located on human chromosome
14q between bands 11.1 to 11.2 and encodes for a 237 amino acid
proteinwith a molecular weight of 26 kDa that is located within the
cellular nucleus. The leucine zipper domain is located between
positions 187e208 (Fig. 1), with characteristic intertwined alpha
helices forming a coil leading to a bifurcation at the DNA binding
sites. The NRL protein is able to dimerise, forming both homo- and
heterodimers. The dimerisation composition inﬂuences DNA
binding, with each dimer subunit independently able to recognise
one half of the recognition sequence, leading to increased binding
speciﬁcity and control of transcription. The additional DNA binding
site in the NRL protein is provided by a basic domain located
between positions 159e185 (Fig. 1A) on the amino terminal side of
the domain.
2. Function
NRL is a transcription factor which regulates the expression of
rod photoreceptor speciﬁc genes including rhodopsin. It binds to& Therapeutics, UCL Institute
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All rights reserved.scription. The NRL protein undergoes post translational modiﬁca-
tion via phosphorylation by mitogen-activated protein kinases. Six
isoforms have been observed in the nuclei of rod but not cone
photoreceptor nuclei in vivo (Swain et al., 2001).
In vitro studies have shown that the leucine zipper domain of
NRL physically interacts with the homeobox protein CRX (also
to an element within the Nr2e3 promoter sequence and enhances
its activity synergistically with CRX to suppress cone differentiation
and promote that of rod photoreceptors. Deletion of NRL in mice
results in a retina with no rods but with a more cone-like nature
(Mears et al., 2001 (cited within Nichols et al., 2010)). Within the
retina, NRL is expressed in rods (Fig. 1B) but can also be identiﬁed
within cells in the pineal gland (Swain et al., 2001).
In keeping with its role in the regulation of rhodopsin expres-
sion, NRL expression precedes that of rhodopsin during rod
photoreceptor development in mammals. Transplantation of
retinal progenitor populations in mice has demonstrated that
successfully integrated rod photoreceptors may be derived from
committed post-mitotic precursors expressing NRL, and not from
proliferating progenitor/stem cells (MacLaren et al., 2006).3. Disease involvement
The inﬂuence of NRL upon rhodopsin expression has led to the
identiﬁcation of mutations within the gene being associated with
forms of retinal degeneration such as retinitis pigmentosa (RP).
Genetic studies of patients affected by autosomal dominant RP
have shown several missense mutations affecting residues
including 50, 51 and 122 of the NRL protein. Subsequent in vitro
work has suggested that the mutations seen in dominant forms of
RP are due to an NRL protein with reduced phosphorylation and
abnormally enhanced transcriptional activation of the rhodopsin
promoter (Kanda et al., 2007). More recent work, however, has
shown that some CRX mutations causing retinal degeneration
reduce NRL activity through aberrant binding, which might
support a separate mechanism of retinal degeneration in humans
through NRL haploinsufﬁciency which is not seen in mice (Nichols
et al., 2010).
Fig. 1. A. Schematic diagram of the human NRL gene and protein. The NRL gene encodes 3 exons, the ﬁrst of which is untranslated due to the absence of an ATG initiation codon.
Annotation of the protein shows the minimal transactivation domain (MTD), hinge region, extended homology domain (EHD), basic domain (BD) and leucine zipper (bZIP). The
locations of altered amino acid residues observed in patients with retinopathies are shown with arrows. (NRL gene and protein diagram adapted from Nishiguchi et al., 2004 (cited
within Kanda et al., 2007.) B. Confocal projection image of a section of adult retina from the Nrl.gfpþ/þmouse demonstrating expression of NRLwithin the outer nuclear layer and rod
inner segments. (RPE, OS, IS, ONL, INL and GCL refer to the retinal pigment epithelium, outer segments, inner segments, outer nuclear layer, inner nuclear layer and ganglion cell
layer respectively. TPM-T ¼ Nomarski image; scale bar ¼ 20 mm).
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sively inherited photoreceptor degeneration. These include
a leucine to proline substitution at residue 160, which results in an
abnormal protein without a bZIP domain that is unable to bind to
the NRE and showed reduced transcriptional activation of the
rhodopsin promoter (Kanda et al., 2007). Recessive disease in some
patients is also associated with the observation of enhanced S-cone
function, as described in the NRL knockout mouse. The identiﬁca-
tion of loss of NRL function (either through haploinsufﬁciency or
recessive disease) as a mechanism is critical for potential gene
replacement therapy. This is because the NRL coding sequence is
small at about 1.25 kb and therefore ideally suited for gene
replacement using adeno-associated viral vectors which are being
tested in a number of clinical trials.
4. Future studies
Investigation into the post translation modiﬁcations of NRL by
phosphorylation and sumoylation may provide further insights
into the regulatory networks controlling rod photoreceptor devel-
opment. The role of proteins such as NRL in circadian rhythms, due
to its identiﬁcation in the pineal gland, may elucidate further
physiological pathways. It is likely that NRL will provide a focus for
emerging translational strategies to improve retinal function
involving gene therapy and stem cells. Single gene mutations
affecting NRL, such as those seen in patients with retinal degener-
ations such as RP, are a potential and realistic target for future gene
therapy studies. Furthermore, the introduction of the concept of an
optimal ontogenetic stage for photoreceptor precursor trans-
plantation in rodents (MacLaren et al., 2006) served as a paradigm
shift for research into stem cell transplantation. Using NRL asa marker of committed rod photoreceptor precursors in vivo may
facilitate the localisation and functional assessment of transplanted
cells, using established methods such as focal electroretinography
or by the development of implantable devices to measure the
electrophysiological response to individual cells. Further work is
required to translate current knowledge regarding NRL into thera-
peutic strategies, including the role of NRL in the differentiation of
human adult-derived retinal stem cells and from other sources
such as induced pluripotent stem cell lines.Acknowledgements
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